Digital Health Technologies Applied by the Pharmaceutical Industry to Improve Access to Noncommunicable Disease Care in Low- and Middle-Income Countries

BACKGROUND: There is limited research on how digital health technologies (DHTs) are used to promote access to care for patients with noncommunicable diseases (NCDs), particularly in low- and middle-income countries (LMICs). We describe the use of DHTs in pharmaceutical industry–led access programs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Heerdegen, Anne Christine Stender, Cellini, Carlotta Maria, Wirtz, Veronika J., Rockers, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622287/
https://www.ncbi.nlm.nih.gov/pubmed/36316151
http://dx.doi.org/10.9745/GHSP-D-22-00072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622287/
https://www.ncbi.nlm.nih.gov/pubmed/36316151
http://dx.doi.org/10.9745/GHSP-D-22-00072

Ejemplares similares